Long-Term Platinum-Based Drug Accumulation in Cancer-Associated Fibroblasts Promotes Colorectal Cancer Progression and Resistance to Therapy

Scientists applied elemental imaging to the mapping of chemotherapy (CT) biodistribution after therapy in residual colorectal cancer and achieved a comprehensive analysis of the genetic program induced by oxaliplatin-based CT in the tumor microenvironment.